Belite Bio
BLTE
8 hedge funds and large institutions have $3.87M invested in Belite Bio in 2022 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 2 increasing their positions, reducing their positions, and 3 closing their positions.
80% more capital invested
Capital invested by funds: $2.15M → $3.87M (+$1.72M)
67% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 3
33% more funds holding
Funds holding: 6 → 8 (+2)
0.19% more ownership
Funds ownership: 0.29% → 0.48% (+0.19%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$633K |
| 2 |
State Street
Boston,
Massachusetts
|
+$367K |
| 3 |
JP Morgan Chase
New York
|
+$256K |
| 4 |
Geode Capital Management
Boston,
Massachusetts
|
+$251K |
| 5 |
Barclays
London,
United Kingdom
|
+$230K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$280K |
| 2 |
BAMF
BI Asset Management Fondsmaeglerselskab
Kobenhavn,
Denmark
|
-$92K |
| 3 |
UBS Group
Zurich,
Switzerland
|
-$21K |
BLTE Hedge Fund Activity: Q3 2022 in Review
8 of the 5,806 institutional investors tracked by Wall St. Rank reported a position in Belite Bio (BLTE) for Q3 2022, worth a combined $3.87M — up 80% from $2.15M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new BLTE positions and 3 closed out — a net gain of 2 holders — while 2 added to existing stakes and 0 trimmed.
The largest buyer was Morgan Stanley, opening a new position worth an estimated $633K. The largest seller was Millennium Management, exiting entirely with an estimated $280K sold.
- 8 institutional investors held Belite Bio (BLTE) as of Q3 2022, up from 6 in Q2 2022.
- Funds reported $3.87M of Belite Bio stock for Q3 2022, up 80% quarter-over-quarter.
- 5 funds opened new Belite Bio positions in Q3 2022 and 3 closed out, a net change of +2 holders.
- The largest Belite Bio buyer in Q3 2022 was Morgan Stanley, an estimated $633K added.
- The largest Belite Bio seller in Q3 2022 was Millennium Management, an estimated $280K sold.
Based on aggregated 13F filings for Q3 2022.